Houlihan Lokey Advises Petauri Health

Houlihan Lokey is pleased to announce that Petauri Health, a purpose-built pharmaceutical services platform backed by Oak Hill Capital (Oak Hill), has acquired The Kinetix Group (TKG), a strategic advisory, access marketing, and medical affairs agency. The terms of the transaction were not disclosed.

The Kinetix Group partners with life sciences companies to effectively engage with health systems, payers, and patients. The company offers a range of services, including strategic consulting, access marketing and branding, health economics and outcomes research, organizational design and transformation, and care pathway development. TKG is headquartered in New York City and employs more than 100 industry professionals supporting over 20 clients, including seven of the top 10 pharmaceutical companies.

Petauri Health is a purpose-built pharmaceutical commercialization services platform based in New York City. Formed by Oak Hill, the platform seeks to actively acquire and combine best-in-class companies with recognized expertise in global market access, medical affairs, patient services, and data and analytics. Oak Hill aims to deploy in excess of $250 million of equity capital from its latest fund (OHCP VI) behind this initiative over time. The resulting platform will work with pharmaceutical and life sciences clients with the goal of improving patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances to support clients with data-driven, digital-forward solutions that speed up patient access to life-changing care.

Oak Hill is a longstanding private equity firm focused on the North American middle market. Oak Hill applies a specialized, theme-based approach to investing in the following dedicated industry sectors: media and communications, industrials, services, and consumer. The firm implements a highly systematic approach to theme development, proactive origination, and value creation in partnership with management to build franchises of lasting value. Over the past 35+ years, Oak Hill and its predecessors have raised approximately $20 billion of initial capital commitments and co-investments, invested in approximately 100 companies, and completed more than 300 add-on acquisitions, representing an aggregate enterprise value at the acquisition of over $60 billion.

Houlihan Lokey served as the exclusive financial advisor to Petauri Health and Oak Hill. This deal highlights Houlihan Lokey’s leading experience in the pharma services space and represents the firm’s 22nd transaction in this sector since 2019.